Showing results (71-80 of 406) with videos related to

Sort By:
Pageof 41
Blood Reviews|April 17, 2021
Improving outcomes for patients with relapsed multiple myeloma: Challenges and considerations of current and emerging treatment optionsKarthik Ramasamy, Francesca Gay, Katja Weisel, et al.
Academic Radiology|September 7, 2010
Response assessment in patients with multiple myeloma during antiangiogenic therapy using arterial spin labeling and diffusion-weighted imaging: a feasibility studyMichael Fenchel, Marina Konaktchieva, Katja Weisel, et al.
Leukemia & Lymphoma|June 28, 2021
Health-related quality of life outcomes from the CANDOR study in patients with relapsed or refractory multiple myelomaDavid Siegel, Katja Weisel, Anita Zahlten-Kumeli, et al.
Skeletal Radiology|April 3, 2015
Improvement of diagnostic confidence for detection of multiple myeloma involvement of the ribs by a new CT software generating rib unfolded images: Comparison with 5- and 1-mm axial imagesGeorg Homann, Katja Weisel, Deedar Farhad Mustafa, et al.
Annals of Hematology|November 16, 2022
VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experienceSusanne Ghandili, Dzenefa Alihodzic, Christian Wiessner, et al.
Anticancer Research|November 24, 2011
Symptomatic bone marrow involvement in breast cancer--clinical presentation, treatment, and prognosis: a single institution review of 22 casesHans-Georg Kopp, Katja Krauss, Tanja Fehm, et al.
Blood|February 28, 2004
The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cellsTakafumi Kimura, Andreas M Boehmler, Gabriele Seitz, et al.
European Journal of Haematology|September 22, 2019
Disease progression and defects in primary hemostasis as major cause of bleeding in multiple myelomaClemens Hinterleitner, Ann-Christin Pecher, Klaus-Peter Kreißelmeier, et al.
Transfusion|July 19, 2003
Peripheral blood cell telomere length measurements indicate that hematopoietic stem cell turnover is not significantly increased in whole blood and apheresis PLT donorsStefan Scheding, Inci Ersöz, Ulrike Hartmann, et al.
Investigational New Drugs|October 31, 2003
An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcomaPeter Reichardt, Karin Oechsle, Daniel Pink, et al.
Pageof 41